VKTX: Viking Therapeutics, Inc. Company Short-Term Debt
Historical short-term debt data provided by GURU.Markets analytics demonstrate the financial trajectory of Viking Therapeutics (VKTX). Growth is driven by the development of breakthrough obesity treatments VK2809 and VK2735. Stability is ensured by US-based R&D centers focused on innovative therapies. Potential is expanding due to colossal demand in metabolic disorder markets, while the 0.01 level serves as a critical benchmark.
Summary analytical data breakdowns for Viking Therapeutics Corp (VKTX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Viking Therapeutics|VKTX - Long-Term Debt to Capital|Short-Term Debt to Capital Viking Therapeutics|VKTX - Company Total Debt Obligations|Debt to Book Capitalization Ratio Viking Therapeutics, Inc.|VKTX - Company Long-Term Indebtedness|Company Short-Term Debts Viking Therapeutics|Quick Liquidity Indicator vikingtherapeutics.com
- earnings and valuation multiples indicators:
Fundamental company analysis:VKTX - Viking Therapeutics, Inc.
Brian Lian's lean capital management in the development of obesity drugs makes the analysis of total current liabilities a key tool for assessing the operational resilience of Viking Therapeutics (VKTX). This indicator aggregates all payments maturing within one year, allowing investors to use the chart's dynamics to determine the balance between the pace of clinical trials and the risk of a liquidity shortage.
Direct competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Current Liabilities ACAD|Company Short-Term Debt XENE|Company Short-Term Debts SUPN|Short-Term Debt Volume Catalyst Pharma|Company Short-Term Debt Denali Therapeutics Inc DNLI|Company Short-Term Debts Harmony Corp HRMY|Biohaven Ltd. - Company Short-Term Debts|Short-Term Debt Volume amylyx.com AMLX|Trevi Therapeutics, Inc. (TRVI) - Company Short-Term Debt|Company Short-Term Indebtedness PRAX|AVXL (Anavex Corp) - Company Short-Term Debts|CBLL - Short-Term Indebtedness|Company Current Liabilities PRTA (Prothena)|ALEC (alector.com) - Company Short-Term Loans and Borrowings|Annexon - Company Current Liabilities|Amount of Current Liabilities OMER (Omeros Corp)|Neurogene Corp - Company Short-Term Debts|Company Short-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR: Company Short-Term Debts|Short-Term Debt neumoratx.com (NMRA)|Company Short-Term Debt Scilex|TVGN: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACOG|Company Short-Term Debts cogrx.com (CGTX)|Company Short-Term Debt Inhibikase Therapeutics IKT|SAVA (cassavasciences.com) - Current Liabilities|Assertio Therapeutics - Company Short-Term Debts|Short-Term Debt Coya Therapeutics, Inc.|VTGN (vistagen.com) - Company Current Liabilities|Ovid Therapeutics (OVID) - Company Short-Term Debts|Company Current Liabilities ABOS|CRVO (cervomed.com) - Amount of Current Liabilities|Company Short-Term Debts ATHE|Short-Term Debt Volume clene.com|Company Short-Term Debts PEPG (PepGen)|JUNS - Company Current Liabilities|RLMD - Company Short-Term Debt|Short-Term Debt Volume annovisbio.com ANVS|GRCE (gracetx.com) - Company Current Liabilities|AIFF (Firefly Neuroscience, Inc.) - Company Short-Term Debt|Company Short-Term Debt ANEW Medical|Company Short-Term Debts NeuroSense Therapeutics, Ltd.|Company Current Liabilities RVPH (Reviva Pharmaceuticals)|Amount of Current Liabilities MTVA|NeurAxis - Company Current Liabilities|HSDT: Company Short-Term Indebtedness|PASG - Company Short-Term Debt|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Current Liabilities ADXN|Company Short-Term Debts Alzamend|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Cortigent Inc (CRGT) - Short-Term Debt|ATXI: Company Current Liabilities|BCLI: Company Short-Term Debt|CARA: Company Short-Term Debts|CHRO - Short-Term Debt Volume|Company Short-Term Debt Eliem Therapeutics, Inc.|Company Short-Term Debts Intra-Cellular|Company Short-Term Debts LBPH|Short-Term Debt Volume Marinus Pharmaceuticals Inc|Company Short-Term Debt NKGen NKGN|NRBO: Company Short-Term Indebtedness|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Indebtedness synaptogen.com (SNPX)|TRVN (Trevena) - Company Current Liabilities|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|Company Current Liabilities WENA|CERE (Cerevel Corp) - Amount of Current Liabilities